Filtrer efter Last updated date SelectEfterFørFrom - To Dato Slutdato Denne uge Denne måned Seneste uge Seneste måned Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Efterlad dette felt tomt Filter Resultater (3800) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Efterlad dette felt tomt Veterinary medicines: highlights of 2021 15 februar 2022NewsVeterinary Human medicines: highlights of 2021 15 februar 2022NewsHumanMedicines Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 7 - 10 February 2022 11 februar 2022NewsHumanCOVID-19PharmacovigilanceReferralsVaccines PRAC recommends suspending hydroxyethyl-starch solutions for infusion from the market 11 februar 2022NewsHumanReferrals EMA starts safety review of Janus kinase inhibitors for inflammatory disorders 11 februar 2022NewsHumanReferrals Initiation of DARWIN EU® Coordination Centre advances integration of real-world evidence into assessment of medicines in the EU 9 februar 2022NewsHumanData on medicines EMA evaluating data on booster dose of COVID-19 vaccine Comirnaty in adolescents 8 februar 2022NewsHumanCOVID-19Vaccines Public consultation on reflection paper on prophylactic use of antimicrobials in animals 8 februar 2022NewsVeterinaryAntimicrobial resistance A stronger role for EMA 31 januar 2022NewsCorporate New gene therapy treatment for patients with relapsed or refractory large B-cell lymphoma 28 januar 2022NewsHumanMedicines 1 … 46 47 48 49 50 Page 50 of 380 51 52 53 54 … 380
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 7 - 10 February 2022 11 februar 2022NewsHumanCOVID-19PharmacovigilanceReferralsVaccines
PRAC recommends suspending hydroxyethyl-starch solutions for infusion from the market 11 februar 2022NewsHumanReferrals
EMA starts safety review of Janus kinase inhibitors for inflammatory disorders 11 februar 2022NewsHumanReferrals
Initiation of DARWIN EU® Coordination Centre advances integration of real-world evidence into assessment of medicines in the EU 9 februar 2022NewsHumanData on medicines
EMA evaluating data on booster dose of COVID-19 vaccine Comirnaty in adolescents 8 februar 2022NewsHumanCOVID-19Vaccines
Public consultation on reflection paper on prophylactic use of antimicrobials in animals 8 februar 2022NewsVeterinaryAntimicrobial resistance
New gene therapy treatment for patients with relapsed or refractory large B-cell lymphoma 28 januar 2022NewsHumanMedicines